CuraSen Therapeutics has commenced its Phase IIa proof-of-concept trial of CuraAX (CST-3056) with dosing of the first patient ...
A dangerous animal sedative called Xylazine is causing a crisis in the US and UK. Often mixed with fentanyl, it intensifies ...
Adoptive T cell therapy has transformed cancer treatment, with chimeric antigen receptor (CAR) T cell therapy demonstrating remarkable clinical success in hematological malignancies. By genetically ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual Congress of the European Association of ...
Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland Background: Euglycemic diabetic ketoacidosis (euDKA) is a rare but potentially life-threatening ...
GLP-1 receptor agonist drugs like Trulicity and Ozempic have proved very effective in managing diabetes and obesity, but because of the way they work, they can present problems when it comes to ...
HealthDay News — Patients with psoriasis treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have better long-term outcomes compared with those taking other diabetes or weight-loss ...
Hemoglobin A1c, fasting glucose, body weight, body mass index, and systolic blood pressure decreased with GLP-1 RA use. HealthDay News — In children and adolescents with type 2 diabetes (T2D) or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback